There are lots of treatment options for seasonal affective disorder, which is linked to less sunlight in winter ...

One or more intruders broke into an Iowa mink farm and released 2,000 of the furbearing animals in what a trade group called a "terrorist act" under federal law.

Qualifying 1 for the Nürburgring 24 Hours brought drama as drivers pushed into the night. A heavy collision shocked the field, while others struggled with darkness and pace. Watch how chaos unfolded ...

The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea, according to a European clinical study in which the University of ...

Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of Neurology and director of the UAB Huntington’s Disease Clinic, reacted to the ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for ...

WOODSIDE, Calif. (KRON) — October has arrived and if you’re looking for spooky fun, you might consider a trip down the Peninsula to the historic Filoli house in Woodside. For the second year running, ...

Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and devastating neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But last ...

Network expands from consumer to enterprise B2B payments as global cross-border B2B flows surpass $180T Celo is the first payments-focused network to launch Nightfall’s zero-knowledge (ZK) rollup ...

Esophageal cancer is classified into adenocarcinoma and squamous cell carcinoma, with dysphagia as a common symptom. Diagnosis involves endoscopy, biopsy, and imaging to confirm cancer presence and ...

VATICAN CITY, Sept 30 (Reuters) - Pope Leo on Tuesday appeared to offer his strongest criticism yet of U.S. President Donald Trump's hard-line immigration policies, questioning whether they were in ...

People affected by Huntington’s disease could at last benefit from the first treatment to slow the fatal neurodegenerative condition. Scientists from University College London (UCL) found patients ...